Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.59 CAD | -2.45% | -5.36% | -52.54% |
May. 14 | Transcript : Aptose Biosciences Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | Aptose Biosciences Q1 Net Loss Falls, on Lower Expenses | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-52.54% | 19.53M | |
+32.44% | 50.85B | |
+0.09% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+10.78% | 26.11B | |
-22.26% | 19.13B | |
+8.44% | 13.05B | |
+27.21% | 12.16B | |
+24.38% | 12.08B |
- Stock Market
- Equities
- APS Stock
- News Aptose Biosciences Inc.
- Aptose Biosciences Brief: Details Executive Management Changes; Announces Resignation of CFO/CBO Jotin Marango; Appoints Philippe Ledru as Chief Commercial Officer